MDL Pubmed artikelen Autoimmune hepatitis following treatment with infliximab for inflammatory bowel disease. Casteren-Messidoro C, Prins G, van Tilburg AJP, Zelinkova Z, Schouten J, de Man RA. J Crohns Colitis 2012;6:630-1. PMID: 22398075. Geen abstract.Comment on: Autoimmune hepatitis during infliximab therapy for Crohn’s disease: a case report. [J Crohns Colitis. 2011]. The global rating scale in clinical practice. Sint Nicolaas J, de Jonge V, de Man RA, ter Borg F, Cahen DL, Moolenaar W, Stolk MF, van Tilburg AJP, Valori RM, van Leerdam ME, Kuipers EJ; SCoPE consortium. Dig Liver Dis. 2012 Nov;44(11):919-24. PMID: 22840567. BACKGROUND: The Global Rating Scale is an endoscopy quality assurance programme, successfully implemented in England. It remains uncertain whether it is applicable in another health care setting. AIM: To assess the applicability of the Global Rating Scale as benchmark tool in an international context. METHODS: Eleven Dutch endoscopy departments were included for a Global Rating Scale-census, performed as a cross-sectional evaluation, July 2010. Two Global Rating Scale-dimensions - ‘clinical quality’ and ‘patient experience’ - were assessed across six items using a range of levels: from level-D (basic) to level-A (excellent). Construct validity was assessed by comparing department-specific colonoscopy Audit data to GRS-levels. RESULTS: For ‘clinical quality’, variable scores were achieved in items ‘safety’ (9%=B, 27%=C, 64%=D) and ‘communication’ (46%=A, 18%=C, 36%=D). All departments achieved a basic score in ‘quality’ (100%=D). For ‘patient experience’, variable scores were achieved in ‘timeliness’ (18%=A, 9%=B, 73%=D) and ‘booking-choice’ (36%=B, 46%=C, 18%=D). All departments achieved basic scores in ‘equality’ (100%=D). Departments obtaining level-C or above in ‘information’, ‘comfort’, ‘communication’, ‘timeliness’ and ‘aftercare’, achieved significantly better Audit outcomes compared to those obtaining level-D (p<0.05). CONCLUSION: The Global Rating Scale is appropriate to use outside England. There was significant variance across departments in dimensions. Most Global Rating Scale-levels were in line with departments’ Audit outcomes, indicating construct validity. The incidence of 30-day adverse events after colonoscopy among outpatiens in the Netherlands. de Jonge V, Sint Nicolaas J, van Baalen O, Brouwer JT, Stolk MF, Tang TJ, van Tilburg AJP, van Leerdam ME, Kuipers EJ; SCoPE consortium. Am J Gastroenterol. 2012 Jun;107(6):878-84. PMID: 22391645. OBJECTIVES: Colonoscopy is the gold standard for visualization of the colon. It is generally accepted as a safe procedure and major adverse events occur at a low rate. However, few data are available on structured assessment of (minor) post-procedural adverse events. 63 WETENSCHAPPELIJK jaarverslag 2012 Pagina 62
Pagina 64Scoor meer met een webwinkel in uw relatiemagazines. Velen gingen u voor en publiceerden publicaties online.
SFG Jaarverslag 2012 Lees publicatie 130Home